Grant: Engage Grants Program
McMaster University
$25,000.00
Improving Cell Encapsulation by Detection and Mitigation of Protruding Cells
EF 2017-18
Résumé
Type 1 diabetics require daily insulin injections for life. Transplanting insulin-secreting beta-type cells is apromising therapeutic strategy that requires an excellent supply of oxygen and nutrients to the transplantedcells, as well as effective immune protection of the transplanted cells, and prevention of cells escaping fromcapsules.Sernova Corp has developed proprietary implantable Cell PouchTM device technologies that becomevascularized and can then be loaded with islets, beta cells or other therapeutic cells. Immunoprotection in theCell PouchTM can be provided by encapsulating these cells in 300 micrometer calcium alginate beads, but thisapproach is now known to lead to some cells protruding through the capsule surfaces, compromising the wholetransplant. Outer calcium alginate shells have been added to coat protruding cells, but this doubles the finalbead diameter, unacceptably increasing dead volume and decreasing insulin secretion capacity. New strategiesfor detecting cell protrusion, and for forming outer shells with lower dead volume, are hence needed.Dr. StËver has expertise in design and evaluation of alginate-based capsules for cell therapies. In this project,his group will develop new 3D quantitative fluorescence assays for protruding cells, and explore the scope fordouble encapsulations with lower dead volume. This information will inform future capsule compositions andmorphologies, in order to optimize cell protection and containment as well as cell function.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
509228-2017
Name nom
StËver, Harald
Department département
Chemistry & Chemical Biology
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
1
Nb partie
1
Application title
Improving Cell Encapsulation by Detection and Mitigation of Protruding Cells
Keyword
NSERC
Application summary
Type 1 diabetics require daily insulin injections for life. Transplanting insulin-secreting beta-type cells is apromising therapeutic strategy that requires an excellent supply of oxygen and nutrients to the transplantedcells, as well as effective immune protection of the transplanted cells, and prevention of cells escaping fromcapsules.Sernova Corp has developed proprietary implantable Cell PouchTM device technologies that becomevascularized and can then be loaded with islets, beta cells or other therapeutic cells. Immunoprotection in theCell PouchTM can be provided by encapsulating these cells in 300 micrometer calcium alginate beads, but thisapproach is now known to lead to some cells protruding through the capsule surfaces, compromising the wholetransplant. Outer calcium alginate shells have been added to coat protruding cells, but this doubles the finalbead diameter, unacceptably increasing dead volume and decreasing insulin secretion capacity. New strategiesfor detecting cell protrusion, and for forming outer shells with lower dead volume, are hence needed.Dr. StËver has expertise in design and evaluation of alginate-based capsules for cell therapies. In this project,his group will develop new 3D quantitative fluorescence assays for protruding cells, and explore the scope fordouble encapsulations with lower dead volume. This information will inform future capsule compositions andmorphologies, in order to optimize cell protection and containment as well as cell function.